Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08HZL
|
||||
Former ID |
DAP001077
|
||||
Drug Name |
Trimeprazine
|
||||
Synonyms |
Alimemazina; Alimemazine; Alimemazinum; Alimezine; Isobutrazine; Methylpromazine; Oxomemazin; Repetin; Teralen; Trimeperazine; Trimeprazine Tartrat; Bayer 1219; Alimemazina [INN-Spanish]; Alimemazine (INN); Alimemazine [INN:BAN]; Alimemazinum [INN-Latin]; Dl-Trimeprazine; Nedeltran (TN); Oxomemazine [DCF:INN]; Panectyl (TN); Repeltin (TN); Temaril (TN); Therafene (TN); Theralen (TN); Theralene (TN); Trimeprazine (BAN); Vallergan (TN); Vanectyl (TN); Trimeprazine 5,5-dioxide; Trimeprazine hemi-(+)-tartrate; N,N,beta-Trimethyl-10H-phenothiazine-10-propanamine; N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine; N,N,2-trimethyl-3-(10H-phenothiazin-10-yl)propan-1-amine; (+-)-Alimemazine; (+-)-Trimeprazine; 10-(2-Methyl-3-dimethylaminopropyl)-phenothiazine; 10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine; 10-(3-Dimethylamino-2-methylpropyl)phenothiazine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihistamines
|
||||
Company |
Allergan Herbert Skin Care Div Allergan Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H22N2S
|
||||
InChI |
InChI=1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3
|
||||
InChIKey |
ZZHLYYDVIOPZBE-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 84-96-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9381, 5664294, 7980834, 8153430, 10536926, 14998583, 26683957, 29224613, 46508449, 47662440, 48416667, 49698896, 50006469, 50543011, 51091464, 57244633, 57322852, 85209689, 92717845, 103216922, 103957784, 104309626, 125824456, 126621947, 126687442, 129976632, 134224850, 134338334, 134972661, 137120698, 141522740, 152102834, 160964578, 178103811, 179038167, 184534350, 198994073, 223441145, 223682819, 226408868, 241155290, 249924803
|
||||
SuperDrug ATC ID |
R06AD01
|
||||
SuperDrug CAS ID |
cas=000084968
|
||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [536153] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References | |||||
Ref 542253 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7237). | ||||
Ref 550775 | Drug information of Trimeprazine, 2008. eduDrugs. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.